Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Nomura raised Uber Technologies, Inc. (NYSE: UBER) price target from $59 to $62. Nomura analyst Anindya Das downgraded the stock from Buy to Neutral. Uber shares fell 0.2% to close at $63.14 on Thursday. See how other analysts view this stock.
- Goldman Sachs boosted the price target for Equifax Inc. (NYSE: EFX) from $195 to $222. Goldman Sachs analyst George Tong maintained a Neutral rating. Equifax shares fell 0.3% to close at $249.61 on Thursday. See how other analysts view this stock.
- Ascendiant Capital boosted the price target for Expedia Group, Inc. (NASDAQ: EXPE) from $133 to $168. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Expedia shares gained 0.02% to close at $153.28 on Thursday. See how other analysts view this stock.
- Ascendiant Capital increased Booking Holdings Inc. (NASDAQ: BKNG) price target from $3,700 to $3,900. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Booking shares gained 0.5% to close at $3,550.47 on Thursday. See how other analysts view this stock.
- BTIG boosted the price target for Natera, Inc. (NASDAQ: NTRA) from $75 to $85. BTIG analyst Mark Massaro maintained a Buy rating. Natera shares gained 1.3% to close at $62.04 on Thursday. See how other analysts view this stock.
- Raymond James cut the price target for ConocoPhillips (NYSE: COP) from $146 to $140. Raymond James analyst John Freeman maintained a Strong Buy rating. ConocoPhillips shares fell 1.7% to close at $116.50 on Thursday. See how other analysts view this stock.
- TD Cowen cut NeoGenomics, Inc. (NASDAQ: NEO) price target from $22 to $19. TD Cowen analyst Dan Brennan maintained an Outperform rating. NeoGenomics shares fell 18.1% to close at $16.79 on Thursday. See how other analysts view this stock.
- Benchmark slashed Altice USA, Inc. (NYSE: ATUS) price target from $10 to $5. Benchmark analyst Matthew Harrigan maintained a Buy rating. Altice USA shares gained 6.6% to close at $3.25 on Thursday. See how other analysts view this stock.
- Mizuho boosted ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) price target from $35 to $40. Mizuho analyst Uy Ear maintained a Buy rating. ACADIA Pharmaceuticals shares fell 1.2% to close at $31.39 on Thursday. See how other analysts view this stock.
- Ascendiant Capital increased Outlook Therapeutics, Inc. (NASDAQ: OTLK) price target from $1.5 to $2. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Outlook Therapeutics shares fell 7.8% to close at $0.4267 on Thursday. See how other analysts view this stock.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Check This Out: How To Earn $500 A Month From Annaly Capital Management Stock
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.